Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach

Overview

Journal Diabetes Ther

Specialty Cardiology & Vascular Diseases

Date 2019 Jun 22

PMID 31222593

Citations 8

Authors

Sandro Gentile

Felice Strollo

Ersilia Satta

Teresa Della Corte

Carmine Romano

Giuseppina Guarino

Affiliations

Soon will be listed here.

Abstract

Introduction: End-stage renal disease (ESRD) is associated with increased cardiovascular mortality (CVM) and diabetes mellitus (DM), which in many cases is treated with insulin. Skin lipohypertrophy (LH) very often occurs in insulin-treated (IT) patients as a consequence of inadequate injection technique and is one of the most prominent contributors to hypoglycemia (HYPO), glycemic variability (GV), and poor metabolic control (PMC).

Method: The aim of our multicenter observational study was to assess LH prevalence at self-injection sites and any possible factors predicting high LH/HYPO rates and GV in 296 dialyzed ITDM patients characterized by 64 ± 7 years of age, 7 ± 2 years disease duration, 2.6 ± 2.2 years dialysis duration, preferred pen utilization (80%), and basal-bolus regimen (87.4%) with self-injections (62.6%) largely surpassing caregiver-assisted ones (16.9%), and a mix of the two injection methods (20.5%).

Results: LH was detected in 57% of patients. Univariate analysis followed by backwards stepwise multivariate logistic regression function showed increased odds for developing LH in patients characterized by needle reuse, smaller injection areas, missed injection site rotation, higher HbA1c levels, and more prominent rates of HYPO and GV.

Conclusion: This was the first time such observation was made. It is now time for further studies aimed at providing evidence also in ESRD ITDM patients for the cause-effect relationship among wrong injection behavior, LH, and poor metabolic control and for the long-term preventative role of suitable educational countermeasures.

Citing Articles

Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium.

Theys K, Vermander S, Annemans L, De Block C, Hermans M, Matthys I Pharmacoecon Open. 2024; 9(2):259-270.

PMID: 39674967 PMC: 11865415. DOI: 10.1007/s41669-024-00547-x.

A Hypothesis on the Progression of Insulin-Induced Lipohypertrophy: An Integrated Result of High-Frequency Ultrasound Imaging and Blood Glucose Control of Patients.

Yu J, Wang H, Zhou M, Zhu M, Hang J, Shen M Diagnostics (Basel). 2023; 13(9).

PMID: 37174907 PMC: 10177501. DOI: 10.3390/diagnostics13091515.

The Role of the Person Focused IARA Model in Reducing Anxiety and Improving Body Awareness and Illness Management in Diabetics with Acquired Lipodystrophy: A Mixed-Method Study.

Viglino F, Sellami M, Broglio F, Scuntero P, Padovan A, Maulini C J Pers Med. 2022; 12(11).

PMID: 36579585 PMC: 9695520. DOI: 10.3390/jpm12111865.

The Economic Burden of Insulin Injection-Induced Lipohypertophy. Role of Education: The ISTERP-3 Study.

Gentile S, Guarino G, Della Corte T, Marino G, Satta E, Pasquarella M Adv Ther. 2022; 39(5):2192-2207.

PMID: 35306633 PMC: 9056437. DOI: 10.1007/s12325-022-02105-5.

Leveraging Mechanical Forces to Target Insulin Injection-Induced Lipohypertrophy and Fibrosis.

desJardins-Park H, Wan D Diabetes Spectr. 2021; 34(3):308-312.

PMID: 34511858 PMC: 8387605. DOI: 10.2337/ds20-0048.

References

Leese G, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W . Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003; 26(4):1176-80. DOI: 10.2337/diacare.26.4.1176. View

Chowdhury T, Escudier V . Poor glycaemic control caused by insulin induced lipohypertrophy. BMJ. 2003; 327(7411):383-4. PMC: 1126795. DOI: 10.1136/bmj.327.7411.383. View

Adrogue H . Glucose homeostasis and the kidney. Kidney Int. 1992; 42(5):1266-82. DOI: 10.1038/ki.1992.414. View

. Hypoglycemia and employment/licensure. Diabetes Care. 2008; 31 Suppl 1:S94. DOI: 10.2337/dc08-S094. View

Cryer P . The barrier of hypoglycemia in diabetes. Diabetes. 2008; 57(12):3169-76. PMC: 2584119. DOI: 10.2337/db08-1084. View

Gentile S, Agrusta M, Guarino G, Carbone L, Cavallaro V, Carucci I . Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes. Acta Diabetol. 2010; 48(2):121-5. DOI: 10.1007/s00592-009-0172-x. View

De Coninck C, Frid A, Gaspar R, Hicks D, Hirsch L, Kreugel G . Results and analysis of the 2008-2009 Insulin Injection Technique Questionnaire survey. J Diabetes. 2010; 2(3):168-79. DOI: 10.1111/j.1753-0407.2010.00077.x. View

. Standards of medical care in diabetes--2012. Diabetes Care. 2011; 35 Suppl 1:S11-63. PMC: 3632172. DOI: 10.2337/dc12-s011. View

Blanco M, Hernandez M, Strauss K, Amaya M . Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013; 39(5):445-53. DOI: 10.1016/j.diabet.2013.05.006. View

10.

Nakatani Y, Matsumura M, Monden T, Aso Y, Nakamoto T . Improvement of glycemic control by re-education in insulin injection technique in patients with diabetes mellitus. Adv Ther. 2013; 30(10):897-906. DOI: 10.1007/s12325-013-0066-8. View

11.

Arnouts P, Bolignano D, Nistor I, Bilo H, Gnudi L, Heaf J . Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties. Nephrol Dial Transplant. 2013; 29(7):1284-300. DOI: 10.1093/ndt/gft462. View

12.

Giorda C, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, Baccetti F . Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study. Acta Diabetol. 2015; 52(5):845-53. DOI: 10.1007/s00592-015-0713-4. View

13.

. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). Nephrol Dial Transplant. 2015; 30 Suppl 2:ii1-142. DOI: 10.1093/ndt/gfv100. View

14.

Park H . Severe Hypoglycemia and Cardiovascular Disease in Type 2 Diabetes. Diabetes Metab J. 2015; 39(6):478-80. PMC: 4696983. DOI: 10.4093/dmj.2015.39.6.478. View

15.

Gentile S, Guarino G, Giancaterini A, Guida P, Strollo F . A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. Springerplus. 2016; 5:563. PMC: 4859222. DOI: 10.1186/s40064-016-1978-y. View

16.

Gentile S, Strollo F, Ceriello A . Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear?. Diabetes Ther. 2016; 7(3):401-9. PMC: 5014793. DOI: 10.1007/s13300-016-0187-6. View

17.

Frid A, Hirsch L, Menchior A, Morel D, Strauss K . Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices. Mayo Clin Proc. 2016; 91(9):1212-23. DOI: 10.1016/j.mayocp.2016.06.011. View

18.

Frid A, Hirsch L, Menchior A, Morel D, Strauss K . Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional. Mayo Clin Proc. 2016; 91(9):1224-30. DOI: 10.1016/j.mayocp.2016.06.012. View

19.

Frid A, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch L . New Insulin Delivery Recommendations. Mayo Clin Proc. 2016; 91(9):1231-55. DOI: 10.1016/j.mayocp.2016.06.010. View

20.

Patil M, Sahoo J, Kamalanathan S, Selviambigapathy J, Balachandran K, Kumar R . Assessment of insulin injection techniques among diabetes patients in a tertiary care centre. Diabetes Metab Syndr. 2016; 11 Suppl 1:S53-S56. DOI: 10.1016/j.dsx.2016.09.010. View